significantly dysregulated small nucleolar RNAs (snoRNA). In particular, we identified 2 dramatically downregulated lncRNAs and 1 downregulated snoRNA whose expression levels correlated significantly with overall patient survival, suggesting their functional significance and clinical relevance in head and neck cancer pathogenesis. We confirmed the dysregulation of these non-coding RNAs in head and neck cancer cell lines derived from different anatomic sites, and determined that ectopic expression of the 2 lncRNAs inhibited key EMT and stem cell genes and reduced cellular proliferation and migration. As a whole, non-coding RNAs are pervasively dysregulated in head and squamous cell carcinoma. The precise molecular roles of the three transcripts identified warrants further characterization, but our data suggest that they are likely to play substantial roles in head and neck cancer pathogenesis and are significantly associated with patient survival.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cancer by incidence worldwide (Ferlay et al. 2010) . Despite advances in treatment and increased knowledge about underlying genetic and environmental risk factors behind the disease, the five-year survival rate for HNSCC has persisted at 50% for more than three decades, with most cases remaining undiagnosed until metastasis (Nemunaitis and O'Brien 2002) . A deeper understanding of the drivers and mechanisms behind HNSCC pathogenesis, as well as continued identification of candidate biomarkers and prognostic factors, is necessary to inform better diagnostic and therapeutic strategies.
While a number of gene mutations and their impacts on signaling pathways have been implicated in HNSCC onset and progression, there still remains much to be elucidated about the role that perturbations in the non-coding genome may play in these processes. Non-coding RNAs (ncRNAs) have been increasingly viewed as key players in human disease, with recent studies establishing their involvement in gene regulation, cell differentiation, self-renewal, and cell proliferation, among other pivotal functions, as well as their dysregulation in many cancers (Esteller 2011) . Existing studies of their roles in HNSCC, however, have primarily focused on profiling microRNAs (Avissar et al. 2009; Childs et al. 2009; Ramdas et al. 2009; Hui et al. 2010 ), a class of small (~22 nt) and relatively well-documented ncRNAs that comprise but a fraction of the non-coding transcriptome (Esteller 2011).
In contrast, long non-coding RNAs (lncRNAs), transcripts exceeding 200 nt in length, are encoded by a large proportion of the so-called "dark matter" of the human genome (Mercer et al. Zou 4 2009; Kapranov et al. 2010) . While a vast majority of lncRNAs remain functionally uncharacterized, the few that are have been linked to a range of biological processes, including chromatin modification, regulation of transcription factors, mRNA processing and degradation, and even cell-cell signaling (Geisler and Coller 2013) . Furthermore, studies suggest that their expression patterns are even more tissue-specific than those of protein-coding genes (Cabili et al. 2011 ) and that they are involved in pivotal tumor suppressive and oncogenic pathways. Increased expression of the lncRNA HOTAIR in primary breast tumors, for instance, was shown to strongly correlate with metastasis and death (Gupta et al. 2010) , with similar upregulation and prognostic significance observed in a number of other cancers, including non-small cell lung cancer and pancreatic cancer (Zhang et al. 2014) . Similarly, overexpression of the lncRNA MALAT-1 has been linked to hepatocellular carcinoma and metastasis in small-cell lung cancer (Lin et al. 2007 ). Several studies of these well-characterized lncRNAs in HNSCC have revealed promising associations as well, with HOTAIR, MEG-3, MALAT-1, and NEAT-1 each exhibiting dysregulation and/or prognostic significance in several subtypes of HNSCC (Fang et al. 2014 , Feng et al. 2012 , Li et al. 2013 , Tang et al. 2013 , Yang and Deng 2014 . Additionally, GAS5
(growth arrest specific transcript 5) has been linked to low expression and poor prognosis in HNSCC (Gee et al. 2011) , and most recently, Shen et al. reported the dysregulation of two relatively uncharacterized transcripts, AC026166.2 and RP11-169D4.1, in LSCCs using microarray and qRT-PCR expression profiling (Shen et al. 2014) . However, aside from these investigations involving mostly known, cancer-associated lncRNAs, the dysregulation and functional significance of lncRNAs in HNSCC has remained largely uncharacterized.
Similarly, small nucleolar RNAs (snoRNAs), which are components of small nucleolar ribonucleoproteins (snoRNPs) and intermediate in length (60-300 nt) (Esteller 2011; Williams and Farzaneh 2012) , are also emerging as potential players in the development of cancer. As facilitators of the methylation and pseudouridylation of rRNA and other post-transcriptional modifications involved in ribosome production (Esteller 2011), snoRNAs were long considered to be merely housekeeping RNAs. Studies, however, have increasingly implicated snoRNA dysregulation as a potential determinant of cell fate and a driver of oncogenesis. Drastic downregulation of human S5 snoRNA genes was observed between meningiomas and normal brain tissue (Chang et al. 2002) , while a panel of six snoRNAs was found to be overexpressed in non-small cell lung cancer (Liao et al. 2010) . More recent studies have revealed that a germline homozygous deletion of 2 base pairs in the snoRNA U50 gene was significantly linked to prostate cancer development, and that a heterozygous genotype for the same deletion, both somatically and in germline, was frequently observed in breast cancers (Dong et al. 2009 ). The identification of dysregulated snoRNAs in multiple cancer types thus far suggests that promising associations between snoRNAs and HNSCC pathogenesis may exist as well.
In our study, we aimed to profile the global expression patterns and dysregulation of lncRNAs and snoRNAs in HNSCC by utilizing RNA-sequencing (RNA-seq), a next-generation deep sequencing technology that captures the transcriptional landscape of the human genome through reverse transcription of isolated RNA and high-throughput sequencing of the resulting cDNA.
By comparing the RNA-seq profiles of lncRNA and snoRNA expression levels in 40 primary HNSCC tumors with those of their matched normal counterparts, we generated a panel of differentially expressed ncRNAs and further characterized selected candidates to gauge the extent of their dysregulation and their functional relevance in HNSCC.
Results

Analysis of primary tumor and matched normal RNA-seq datasets uncovers widespread dysregulation of lncRNAs and snoRNAs in HNSCC
To identify HNSCC-associated lncRNAs, we searched for alterations in their expression using RNA-seq data from 40 patients in The Cancer Genome Atlas (TCGA) repository (Table 1a, Additional File 8a). For each of these patients, raw sequence data of both the primary HNSCC tumor and matched adjacent normal tissue were available. To profile lncRNA expression levels, we mapped each RNA-seq library to a reference annotation of 32,108 human lncRNAs. Using the R/Bioconductor package edgeR, we filtered and normalized the read count data and compared lncRNA expression, in the form of counts-per-million (cpm), between HNSCC and normal samples. From the 12,407 consistently detected lncRNA transcripts and isoforms, a total of 7,120 differentially expressed lncRNAs (FDR < 0.05) were identified between the HNSCC and adjacent normal tissues (Figure 1 ). Among these, 2,808 transcripts were differentially well (Gee et al. 2011 ). While we found GAS5 downregulation in HNSCC to be statistically significant, with 29 splice isoforms of the lncRNA appearing in our original panel of 7,120 differentially expressed lncRNA transcripts, the difference in GAS5 expression levels between HNSCC and normal tissues was determined to be less than 2-fold with p > 0.0001, so we did not identify GAS5 as a candidate for further study (Additional File 3). MEG-3 (maternally expressed gene 3), a tumor suppressor lncRNA implicated in p53 activation (Zhang et al. 2010) , was also downregulated in HNSCCs by less than 2-fold, p > 0.0001 (Additional File 3). We observed no significant dysregulation of many other lncRNAs previously linked to cancers, including HOTAIR, MALAT-1, ANRIL, NEAT-1, and UCA-1, in our overall cohort.
To investigate possible heterogeneity in lncRNA expression among different HNSCC tumor sites, we stratified our patients by anatomic subdivision (Table 1a) and performed tumor vs.
paired normal differential expression analysis on each subcohort using edgeR. Among our 15 patients presenting oral squamous cell carcinoma, 777 lncRNA transcripts were differentially expressed by at least ±4-fold (p < 0.0001). Notably, we found that HOTAIR was significantly upregulated and numerous splice isoforms of MEG-3 and GAS5 were downregulated in primary tumors (Additional File 4a). Meanwhile, analysis of the 13 tongue squamous cell carcinoma pairs yielded 1,020 lncRNA transcripts dysregulated by ≥ 4-fold in magnitude (p < 0.0001), with downregulation observed in GAS5 (Additional File 4b ). Finally, in our 11 tumor-normal laryngeal squamous cell carcinoma (LSCC) paired samples, we found 657 lncRNA transcripts deregulated by at least ±4-fold. While none of the aforementioned well-documented lncRNAs were determined to be dysregulated in LSCC, we did observe slight downregulation of RP11-169D4.1 (Additional File 4c), a lncRNA recently associated with survival in LSCC patients (Shen et al. 2014 ).
Univariate and multivariate analyses reveal 2 lncRNAs and 1 snoRNA significantly associated with HNSCC patient outcome
We next examined the relationship between the expression levels of selected ncRNAs in HNSCC patients and overall survival in order to determine which lncRNAs and snoRNAs could potentially be of functional significance in HNSCC pathogenesis. We measured the expression levels of the 30 most significantly dysregulated lncRNAs in an additional 45 randomly selected HNSCC RNA-seq datasets from TCGA, doubling the size of our cohort (n = 85), and modeled lncRNA expression level as a binary variable, with the "low" group corresponding to the 50% of HNSCC patients with relative low expression of the lncRNA, and "high" corresponding to the 50% of HNSCC patients exhibiting relative high expression of the lncRNA. Low expression of 2 lncRNAs that RNA-seq analysis identified as dramatically downregulated in HNSCC, lnc-LCE5A-1 and lnc-KCTD6-3 (Table 2) , correlated with poor survival under univariate KaplanMeier analysis, with a Cox regression model also yielding significant results (lnc-LCE5A-1: p = 0.048, Hazard Ratio (HR) = 1.65; lnc-KCTD6-3: p = 0.032, HR = 1.73) (Figure 4a-b) . We obtained snoRNA expression profiles from an additional 99 randomly selected HNSCC tumors from TCGA, resulting in a cohort of size of n = 130. Univariate analysis revealed that lower expression of SNORD35B (U35B), a snoRNA downregulated in HNSCC, served as an adverse prognostic factor for survival, with Cox regression analysis also finding significant correlation (p = 0.009, HR = 1.94) (Figure 4c ).
We then performed multivariate analysis for lnc- and SNORD35B and found that expression of these 3 non-coding RNAs operated as prognostic factors independent of established clinical risk factors, including pathologic stage and tumor grade, among other patient characteristics (Table 3) . To eliminate age as a confounding variable in patient survival and ncRNA expression level, we conducted a secondary analysis excluding patients > 85 years of age. Additionally, we modeled patient age as both a continuous and binary covariate (< or >= 75 years) in order to capture nonlinear associations between patient age and survival. Under this analysis, we found that high vs. low expression of all three ncRNAs remained a significant independent predictor of patient outcomes (Additional File 5).
Transcript characterization and coverage mapping of survival-associated ncRNAs
Visualization of both lncRNAs in the Ensembl genome browser revealed their antisense overlap with protein-coding regions, while SNORD35B was found to be encoded in an intron of RPS11 ( Figure 5 ). To confirm that the mapped reads spanned the entirety of our identified lncRNAs, we plotted the average per-base coverage of each exon in the lncRNAs (Additional File 6a-b). We also compared the sequences and locations of SNORD35B and its paralog, SNORD35A (Additional File 6c). Zou 10 To verify the dysregulation of lnc-LCE5A-1, lnc-KCTD6-3, and SNORD35B, we examined their relative expression in two normal oral epithelial cell lines (OKF4 and OKF6) compared to five established HNSCC cell lines (UMSCC-10B, UMSCC-22B, HN-1, HN-12, and HN-30) using real-time qRT-PCR (quantitative reverse transcriptase PCR). We found that the three ncRNAs were nearly exclusively downregulated in the HNSCC cell lines, although lnc-LCE5A-1 and lnc-KCTD6-3 were both downregulated to a lesser extent than predicted by RNA-seq analysis of the patient sequence data (Figure 6 ). Because the expression of EMT-related genes was consistently altered in lncRNA-transfected cells, we examined whether these lncRNAs could inhibit cell migration, a key component of the EMT phenotype, using wound healing migration assays. Over a 24-hour period, we observed markedly reduced migration of lnc-LCE5A-1 and lnc-KCTD6-3-transfected HNSCC cells as compared to vector-transfected controls (Figure 8 ). Zou 11 Additionally, to investigate the effects of both lncRNAs on cell proliferation, we performed an MTS assay on lnc-LCE5A-1 and lnc-KCTD6-3-transfected HNSCC cell lines. Both lncRNAs led to a reduction in proliferation of at least 25% over 3 days (Figure 9 ).
In-vitro verification of survival-associated ncRNAs
Overexpression of
Discussion
The molecular basis of HNSCC has largely been studied in the context of environmental risk To our knowledge, this is the first study utilizing next-generation sequencing to globally profilethe dysregulation of lncRNAs and snoRNAs in HNSCC. We first compiled and compared the expression patterns of 32,108 lncRNA transcripts in HNSCC and adjacent normal tissues.
Among the 12,407 lncRNA transcripts consistently detected in these samples, nearly one-fourth (2,808) were significantly differentially expressed in HNSCC by a fold change of A number of studies have identified molecular distinctions among HNSCCs of varying anatomic origin (Belbin et al. 2008 , Kokko et al. 2011 , Lleras et al. 2013 , Rodrigo et al. 2001 ). CD44 expression, for instance, was found to be predictive of five-year survival in primary pharyngeal and laryngeal tumors, but not in tumors arising in the oral cavity (Kokko et al. 2011 ).
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Meanwhile, genome-wide methylation profiling revealed unique DNA methylation signatures associated with different HNSCC anatomic sites (Lleras et al. 2013) . Given the tissue specificity of lncRNAs and their prolific involvement in many aspects of genomic and transcriptional regulation (Cabili et al. 2011) , changes in lncRNA expression may contribute to the emergence of site-specific characteristics in HNSCC.
To further study anatomic site-specific lncRNA expression and dysregulation, we stratified our patients by primary tumor site (oral, tongue, and laryngeal) and performed differential expression analysis on each subcohort. We found significant dysregulation of HOTAIR and MEG-3 in oral squamous cell carcinomas, consistent with a prior study by Tang et al. (Tang et al. 2013);  however, in contrast with their report, we observed no significant dysregulation of NEAT-1 or UCA-1. We also found no significant overexpression of UCA-1 in our 13 patients with tongue squamous cell carcinoma (TSCC), although its dysregulation was previously reported by Using RNA-seq, we were able to quantify the expression levels of not only known, cancerassociated lncRNAs, but also those of previously uncharacterized lncRNA transcripts. Despite evidence of key variations at the molecular level distinguishing certain HNSCC subtypes, we were able to identify universal alterations in the transcriptomic landscape of HNSCC that occurred regardless of the roles of environmental factors or anatomic sites in HNSCC etiology.
To identify lncRNAs and snoRNAs with the greatest potential functional significance, we examined the correlation between the expression levels of our candidate transcripts in HNSCC patients and these patients' overall survival using univariate and multivariate Cox regression analyses, identifying 2 lncRNAs, lnc-LCE5A-1 and lnc-KCTD6-3, and 1 snoRNA, SNORD35B, whose low expression in HNSCC tumors was significantly associated with poor survival. We are the first to associate these two lncRNAs with disease, as well as the first to implicate snoRNAs as both widely dysregulated and prognostically significant in HNSCC.
We verified the dysregulation of these three transcripts in-vitro by comparing their expression levels in normal oral epithelial cell lines with those in HNSCC cell lines. We did find that the fold changes of these ncRNAs between HNSCC and normal cell lines were inconsistent with those predicted by the RNA-seq patient data analysis, with lnc-LCE5A-1 and lnc-KCTD6-3 exhibiting a significantly more moderate degree of dysregulation than indicated by the clinical data. Such a disparity may be attributed to the fact that the cell lines were not matched samples; furthermore, dramatically reduced differences in endogenous lncRNA expression between normal and cancerous cell lines appears to be a feature in other lncRNA studies as well (Gupta et al. 2010) . Like SNORD35B, SNORD35A was also predicted to facilitate methylation of 28S rRNA in terms of canonical snoRNA function, and we found it to be significantly downregulated in HNSCCs as well (Additional File 2). These parallels suggest that SNORD35B, as a trans-duplicated paralog of SNORD35A with sequence and structural similarity (Additional File 6), may similarly assume a repertoire of non-nucleolar or non-ribosomal functions. Functional analysis of both paralogs in the context of cancer would therefore be valuable, and could further cement snoRNAs as a novel and potentially fruitful source of insight into HNSCC pathogenesis.
Conclusions
Our findings suggest that dysregulation of the non-coding transcriptome in HNSCC is both extensive and enormously complex. In particular, we have identified three transcripts whose expression levels correlate significantly to patient survival, including two novel lncRNAs that confer a tumor suppressive phenotype. Although further characterization of their molecular mechanisms remains necessary, these ncRNAs may play functionally vital roles in HNSCC pathogenesis. Taken as a whole, our findings demonstrate that RNA-seq transcriptome profiling on matched tumor and normal pairs generates novel insights into cancer biology, resulting in the implication of many previously uncharacterized elements in HNSCC pathogenesis and also yielding findings that may be applicable to other malignancies.
Methods lncRNA Expression Profiling:
RNA-seq libraries were obtained from The Cancer Genome Atlas (TCGA) (https://tcgadata.nci.nih.gov/tcga/), which contained 40 patients with either RNASeq or RNASeqv2 data for HNSCCs (arising in the oral cavity, tongue, or larynx) and their adjacent normal tissue samples (TCGA IDs in Additional File 8). For each of these datasets, sequence reads had been aligned Zou 19 using the BWA algorithm (http://bio-bwa.sourceforge.net/, default parameters) to a reference transcript database derived from hg19 (UCSC).
A BED annotation file containing 32,108 human lncRNA transcripts and splice isoforms was downloaded from LNCipedia (Volders et al. 2013 ), a database curating lncRNA structures and sequences from multiple sources, including the lncRNAdb, Broad Institute, Ensembl, Gencode, and NONCODE. The BEDtools utility coverageBed (Quinlan and Hall 2010) was used to generate lncRNA expression values in the form of integer read counts for each dataset by computing the number of alignments from each library that overlapped each lncRNA feature given by the annotation file.
snoRNA Expression Profiling:
RNAseqv2-generated expression profiles of known snoRNAs were available in TCGA for 31
HNSCCs (arising in the oral cavity, tongue, or larynx) and their adjacent normal tissues (TCGA IDs in Additional File 8). snoRNA expression values in the form of integer read counts were obtained for each dataset.
lncRNA and snoRNA Differential Expression Analysis:
Using the R/Bioconductor software package edgeR (http://www.bioconductor.org/packages/release/bioc/html/edgeR.html), differential expression analysis was performed on the lncRNA and snoRNA read count data produced for the HNSCC and normal sample pairs. lncRNAs and snoRNAs with very low expression (counts per million < 1 for more than one-half of the samples) were excluded from the analysis. Recalculation and accounting for differences between sample library sizes was accomplished by using trimmed mean of M-values (TMM) to compute normalization factors.
To accommodate the paired nature of the experimental designs, the negative binomial generalized linear model (GLM) functionality in edgeR, along with Cox-Reid dispersion Zou 20 estimates, was employed. These methods have demonstrated success in assessing differential expression in multi-factor experiments while appropriately accounting for biological and technical variation (McCarthy et al. 2012) . lncRNAs and snoRNAs whose fold changes were found to vary between HNSCC and paired normal samples by a fold change magnitude greater than 1 and whose false discovery rates (FDR) fell below 0.05 were identified by edgeR to be differentially expressed. To form a more selective panel of lncRNAs for further analysis, filtering of the edgeR lncRNAs was performed based on the following criteria: |HNSCC/Normal| IDs used listed in Additional File 9). The Statsoft software STATISTICA was used for survival models.
Cell Lines and Cell Culture:
The two non-cancerous oral epithelial cell lines used in the qRT-PCR experiments, OKF4 and OKF6, were gifts from the Rheinwald Lab at Harvard Medical School. Both were cultured in Keratinocyte-SFM(1X) with L-glutamine, supplemented with 0.2 ng/mL human recombinant epidermal growth factor (EGF) 1-53, 25 ug/mL bovine pituitary extract (BPE), 0.3 mM calcium chloride, and penicillin streptomycin. Once they attained 30% confluency, they were cultured in equal parts supplemented Keratinocyte-SFM medium and DFK medium. DFK was made with equal parts DMEM and F-12 and supplemented with 0.2 ng/mL EGF 1-53, 25 ug/mL BPE, 2mM L-glutamine, and penicillin streptomycin. 
Validation of Differential Expression by qRT-PCR:
Total RNA was isolated using the RNeasy mini kit (QIAGEN). After polyadenylation (Ambion) and annealing of 1.0 μ g total RNA, cDNA was synthesized using M-MLV reverse transcriptase 
lncRNA Expression Plasmid Transfection:
Expression plasmids for lnc-LCE5A-1 and lnc-KCTD6-3 were custom-designed (Life Technologies) by cloning the respective lncRNA sequences into the pUC19 vector. Plasmids were transiently transfected using Lipofectamine 2000 (Invitrogen), following the manufacturer's specifications. The pUC19 empty vector was used as a control and transfection efficiency for all three plasmids was monitored using GFP as a reporter.
Quantitative Real-Time PCR for Stem Cell and EMT Gene Expression:
Total RNA was collected 48 hours after transfection with the lncRNA expression plasmids using the RNeasy mini kit (QIAGEN). cDNA was synthesized using the Superscript III RT-PCR kit 
MTS Cell Proliferation Assay
UMSCC-10B, UMSCC-22B, HN-1, and HN-30 cells were plated into a 96-well flat-bottom tissue culture plate (Falcon) at a density of 5,000 cells per well. After a 24-hour plating period, cells were transfected with the lncRNA expression plasmids. Following a 48-to 72-hour incubation period, cellular proliferation was analyzed using the CellTiter 96 AQueous nonradioactive proliferation assay (Promega) in accordance with the manufacturer's protocol. All assays were performed in triplicate wells and experiments were individually performed twice.
Wound Healing Migration Assay:
UMSCC-10B and UMSCC-22B cells were cultured in 6-well plates until confluent and were transiently transfected with the lncRNA expression plasmids. 48 hours after transfection, a line in the plate was scored using a P200 pipette tip. The cells were incubated in growth medium, and Zou 24 at each 12-hour interval, the scratched wound was photographed using a light microscope (Nikon Eclipse TE2000-U).
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